Price Target Changes｜XOM Raised to $107 By MS; Snap Lowered to $30 By DB
Benzinga2022-06-06
- Citigroup cut PVH Corp. price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday.
- Morgan Stanley Maintains Overweight on Exxon Mobil, Raises Price Target to $107 XOM shares rose 0.18% to $6.31 in pre-market trading.
- Deutsche Bank Maintains Buy on Snap, Lowers Price Target to $30.
- Barclays lowered RH price target from $528 to $400. RH shares rose 0.5% to $306.00 in pre-market trading.
- HC Wainwright & Co. reduced the price target on Bit Digital, Inc. from $14 to $4. Bit Digital shares rose 6.7% to $1.75 in pre-market trading.
- Morgan Stanley raised CrowdStrike Holdings, Inc. price target from $195 to $215. CrowdStrike shares rose 4.3% to $168.99 in pre-market trading.
- Needham cut price target for Mereo BioPharma Group plc from $10 to $5. Mereo BioPharma shares rose 0.9% to $0.5750 in pre-market trading.
- RBC Capital raised ResMed Inc. price target from $233 to $244. ResMed shares fell 1.4% to close at $208.31 on Friday.
- Goldman Sachs cut the price target on Lincoln National Corporation from $78 to $60. Lincoln National shares rose 1.3% to $56.40 in pre-market trading.
- SVB Leerink raised the price target on Seagen Inc. from $155 to $159. Seagen shares slipped 0.1% to $139.92 in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
